Prospective evaluation of free radicals and antioxidant activity following 6-month risedronate treatment in patients with postmenopausal osteoporosis

Rheumatology International

Volumn 32, Issue 4, 2012, Pages 875-880

  Zinnuroglu, Murat ^a   Dincel, Aylin Sepici ^a,b   Kosova, Funda ^a,c   Sepici, Vesile ^a   Karatas, Gulcin Kaymak ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b UFUK UNIVERSITY   (Turkey)

^c CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Free radicals; Postmenopausal osteoporosis; Risedronate

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; FREE RADICAL; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OXYGEN RADICAL; RISEDRONIC ACID; SUPEROXIDE DISMUTASE; VITAMIN D;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BONE ATROPHY; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HUMAN; LIPID PEROXIDATION; OUTCOME ASSESSMENT; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SCORING SYSTEM; TREATMENT DURATION;

AGED; ANTIOXIDANTS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; ETIDRONIC ACID; FEMALE; FREE RADICALS; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OXIDATIVE STRESS;

EID: 84863528743     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1708-7     Document Type: Article

References (37)

1. Imam A, Iqbal J, Blair HC, Davies TF, Huang CL, Zallone A, Zaidi M, Sun L (2009) Role of the pituitary-bone axis in skeletal pathophysiology. Curr Opin Endocrinol Diabetes Obes 16(6): 423-429
2. Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116(5):1186-1194
3. Hofbauer LC, Heufelder AE (2001) Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 79(5-6):243-253 (Pubitemid 32646379)
4. Olinski R, Gackowski D, Foksinski M, Rozalski R, Roszkowski K, Jaruga P (2002) Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic Biol Med 33(2):192-200 (Pubitemid 34775191)
5. Mazière C, Louvet L, Gomila C, Kamel S, Massy Z, Mazière JC (2009) Oxidized low density lipoprotein decreases Rankl-induced differentiation of osteoclasts by inhibition of Rankl signaling. J Cell Physiol 221(3):572-578
6. Banfi G, Iorio EL, Corsi MM (2008) Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med 46(11): 1550-1555
7. Oldham KM, Bowen PE (1998) Oxidative stress in critical care: is antioxidant supplementation beneficial? J Am Diet Assoc 98:1002-1008
8. Sies H (1993) Strategies of antioxidant defense. Eur J Biochem 215:213-219 (Pubitemid 23224303)
9. Krinsky NI (1992) Mechanism of action of biological antioxidants. Proc Soc Exp Biol Med 200:248-254
10. Frei B, Stocker R, Ames B (1988) Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci 85:9748-9752 (Pubitemid 19027202)
11. Sardesai VM (1995) Role of antioxidants in health maintenance. Nutr Clin Pract 10:19-25
12. Schiller HJ, Reilly PM, Bulkley GB (1993) Antioxidant therapy. Crit Care Med 21:S92-S102 (Pubitemid 23057720)
13. Melhus H, Michaëlsson K, Holmberg L, Wolk A, Ljunghall S (1999) Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 14(1):129-135 (Pubitemid 29021613)
14. Warnholtz A, Wendt M, August M, Münzel T (2004) Clinical aspects of reactive oxygen and nitrogen species. Biochem Soc Symp 71:121-133 (Pubitemid 41185481)
15. Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group Osteoporos Int 4:368-381
16. Yoshioka T, Kawada K, Shimada T, Mori M (1979) Lipid peroxidation in maternal and cord blood and protective mechanisms against activated oxygen toxicity in the blood. Am J Obstet Gynecol 135:372-376 (Pubitemid 9253643)
17. Hammouda AE, Soliman SF, Tolba KA, El-Kabbany ZA, Makhlouf MS (1992) Plasma concentrations of lipid peroxidation products in children with acute lymphoblastic leukaemia. Clin Chem 38:594-595
18. Draper HH, Hadley M (1991) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421-431
19. Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34(3):497-500
20. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte GPx. J Lab Clin Invest 70(1):158-169
21. Mishra OP, Delivoria-Papadopoulos M, Wagerle LC (1990) Antioxidant enzymes in the brain of newborn piglets during ischemia followed by reperfusion. Neuroscience 35(1):211-215 (Pubitemid 20113984)
22. Frei B (1994) Reactive oxygen species and antioxidant vitamins. Mechanism of action. Am J Med 97(3A):5-13
23. Halliwell B, Gutteridge JMC (1990) Free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186:1-85 (Pubitemid 20279941)
24. Halliwell B (1991) Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 91(3):14-22
25. Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18(9):685-716 (Pubitemid 32948277)
26. Michiels C, Raes M, Toussaint O, Remacle J (1994) Importance of Se-glutathione peroxidase, catalase and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 17:235-248
27. Gutteridge JMC, Halliwell B (1994) Antioxidants in nutrition, health and disease. Oxford University Press, New York, Tokyo
28. Danh HC, Benedetti MS, Dostert P (1983) Age-related changes in aldehyde dehydrogenase activity of rat brain, liver, and heart. J Neurochem 41:618-622 (Pubitemid 13050061)
29. Dombrecht EJ, De Tollenaere CB, Aerts K, Cos P, Schuerwegh AJ, Bridts CH, Van Offel JF, Ebo DG, Stevens WJ, De Clerck LS (2006) Antioxidant effect of bisphosphonates and simvastatin on chondrocyte lipid peroxidation. Biochem Biophys Res Commun 348(2):459-464 (Pubitemid 44188591)
30. Ozgocmen S, Kaya H, Fadillioglu E, Yilmaz Z (2007) Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Arch Med Res 38(2):196-205 (Pubitemid 46080543)
31. Hahn M, Conterato GM, Frizzo CP, Augusti PR, da Silva JC, Unfer TC, Emanuelli T (2008) Effects of bone disease and calcium supplementation on antioxidant enzymes in postmenopausal women. Clin Biochem 41(1-2):69-74 (Pubitemid 350216835)
32. Badr SAE, Badr EAE, Hammouda GE, Hadhoud M, Soliman SG, Pandey D (2008) Oxidative stress and some antioxidant parameters in postmenopausal osteoporotic women with fractures: a case control study. Turk J Geriatrics 11(4):174-180
33. Mody N, Parhami F, Sarafian TA, Demer LL (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31(4):509-519 (Pubitemid 32728438)
34. Meagher EA, Fitzgerald GA (2000) Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med 28:1745-1755
35. Maggio D, Barabani M, Pierandrei M, Polidori CM, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A (2003) Marked decreased in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88(4):1523-1527 (Pubitemid 36623364)
36. Zwart SR, Oliver SA, Fesperman JV, Kala G, Krauhs J, Ericson K, Smith SM (2009) Nutritional status assessment before, during, and after long-duration head-down bed rest. Aviat Space Environ Med 80(5 Suppl):A15-A22
37. Zinnuroglu M, Sepici Dincel A, Sepici V, Kaymak Karatas G (2006) Changes in serum and urine N-telopeptide levels of postmenopausal osteoporotic patients within 6-months of risedronate treatment. From World Osteoporos 12(3):55-59